Latest Breaking News On - Global program leaders - Page 1 : comparemela.com

Results provide the first clinical evidence to suggest that afimetoran may offer a benefit to patients with cutaneous lupus erythematosus.

Jonathan sadehBristol myers squibbAmerican college of rheumatologyGlobal program leadersSeverity index activityAmerican college